RFK Jr's vaccine panel to review long-approved jabs for children
The health secretary sparked uproar when he removed all 17 members of the ACIP on 9 June, and then hand-picked eight new members to serve on the panel - including one who dropped out hours before the first meeting.Wednesday's meeting began with the new chair Dr Martin Kulldorff telling the panel that he was fired from his job as a professor at Harvard University because he refused to get a Covid-19 vaccine. Dr Kulldorff also announced the panel would launch new working groups to examine child vaccination schedules and vaccines that were approved seven or more years ago. He said it would be reviewed whether it was "wise" to give the hepatitis B vaccines to newborns, a shot proven safe and effective at preventing the infection that causes liver cancer.Vaccine schedules for measles would also be reviewed, he said.Examining vaccines licensed seven or more years ago raises concerns, because it suggests the process to approve them was flawed, said Bill Hanage, a professor of epidemiology at Harvard TH Chan School of Public Health."I cannot think of any rational reason you would look at that and think it to be the case," he said.The panel was initially meant to vote on recommendations for shots against RSV, a respiratory virus that can be dangerous for infants, but that has been postponed. On Thursday, the group is scheduled to hear a presentation on the use of thimerosal in vaccines given by Lyn Redwood, a former leader of Children's Health Defense, an anti-vaccine group Kennedy used to run.Ms Redwood has been hired by the CDC to work in its vaccine safety office, according to the BBC's US partner CBS News.The decision for the panel to discuss thimerosal, a mercury-based preservative that has not been used in most vaccines for decades, is perplexing, Dr Hanage said. In the past, he said, Acip's members had a wide range of vaccine expertise and would scrutinise vaccine recommendations for months.This time, Kennedy chose for the panel "people that are like him - people in the past who have shown an anti-vaccine bias", said Dr Paul Offit, a former Acip member and director of the Vaccine Education Center at Children's Hospital of Philadelphia.One of the new Acip members was Dr Michael Ross, however he withdrew this week ahead of a review of members' financial holdings, the Department of Health and Human Services said.Kennedy's panel choices have also sparked criticism from Republican Senator Bill Cassidy, a physician who was sceptical of voting to confirm Kennedy as health secretary because of his stances on vaccines.In a post on X, Cassidy said the panel should not proceed with their meeting because of the group's small size and the lack of a CDC director in place to approve their recommendations."Although the appointees to ACIP have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology," he wrote. "In particular, some lack experience studying new technologies such as mRNA vaccines, and may even have a preconceived bias against them."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
14 minutes ago
- The Independent
Faith-based activist groups celebrate after Costco bails on selling abortion pill
Costco has opted not to dispense abortion pills after receiving demands from activists on both sides of the issue — and faith-based groups are celebrating the move. Last year, New York City Comptroller Brad Lander urged the retail giant to get a certification to be able to dispense mifepristone — one drug in a two-drug regimen for medication abortions — at its pharmacies. The following month a religious coalition pleaded with Costco not to sell the termination pill. The FDA allows only certified prescribers to dispense mifepristone. Costco chose to forego pursuing this certification, the company said in a statement to Reuters emphasizing the decision was based on a lack of consumer demand. "Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers,' the company said. Bloomberg first reported Costco's decision. The Independent has reached out to Costco for more information about its decision. Representatives on both sides of the abortion debate have battled over Costco's position in the form of letters. Last July, Lander penned a letter to CEO Ron Vachris demanding the retailer 'immediately take the necessary steps to receive certification' to sell mifepristone, following in the steps of CVS and Walgreens. The comptroller also wrote letters to the leaders of Walmart, Kroger, Albertsons, and McKesson. 'By failing to become certified mifepristone dispensers, these pharmacy giants put both women's reproductive health care and investors' money at risk,' he said in a statement at the time. In August 2024, a coalition of religious activists wrote to Vachris, urging Costco to 'continue its current practice of not dispensing the abortion drug mifepristone.' The group argued that dispensing the drug will reduce demand for the diapers and formula that the store sells and worsen the 'the crisis of record low birth rates.' The letter also alleged the pill poses 'serious health risks.' The FDA first approved the drug in 2000 to end pregnancy through 10 weeks of gestation, but anti-abortion activists have recently challenged its safety and FDA approval. Last year, the Supreme Court unanimously ruled to preserve access to the crucial drug, as nearly two-thirds of all abortions in the U.S. — 63 percent — are medication abortions, according to the Guttmacher Institute. 'Costco's decision to refuse to dispense mifepristone is disappointing and short-sighted,' a spokesperson for Lander told The Independent in a statement. Failure to provide access to proven safe and FDA-approved medication under the guise of 'weak demand' risks isolating customers and undermines the company's credibility. Putting customer needs before political ideology must remain Costco's priority.' Faith-based activists have celebrated the decision. 'We applaud Costco for doing the right thing by its shareholders and resisting activist calls to sell abortion drugs,' Alliance Defending Freedom Legal Counsel Michael Ross said in a statement Thursday. 'They have nothing to gain and much to lose by becoming abortion dispensaries.' 'We have this momentum,' Tim Schwarzenberger, director of corporate engagement at Inspire Investing, the world's largest faith-based ETF provider, told Bloomberg. 'Now there is a chance to turn to some of the other retailers.' 'We are so grateful that Costco—a company that serves families, especially large ones—has decided to remain a wholesale store, not become an abortion facility,' Mary Szoch, director of the Center for Human Dignity at evangelical think-tank Family Research Council, said in a statement on X. 'What a win for America! Great job, @Costco!" CVS and Walgreens, which both dispense the drug, have stood by their decisions in the wake of Costco's announcement. 'We have a long history of supporting and advancing women's health and we remain focused on meeting their unique health needs. This includes providing access to safe, legal, and evidence-based reproductive health services,' CVS told The Independent in a statement, noting that the company fills prescriptions in states where it's legal. Walgreens declined to comment. Its website states: "The U.S. Supreme Court's ruling on mifepristone access allows Walgreens to continue to dispense mifepristone under the FDA guidelines.' The abortion landscape has been complicated after the fall of Roe v. Wade in 2022. In January 2023, the FDA removed some restrictions around accessing mifepristone and added the pharmacy certification. Individuals living in states that have banned the procedure cannot access the drug at pharmacies; 12 states have total abortion bans, according to Guttmacher Institute. The 2022 Supreme Court ruling overturning Roe has opened the door for abortion opponents to argue fresh legal challenges. Earlier this year, anti-abortion activists pushed a report by right-wing think tank Ethics and Public Policy Center claiming serious complications from mifepristone use were 22 times higher than previously reported. Critics blasted the report as 'bogus.'
The Independent
14 minutes ago
- The Independent
4th person dies after a Legionnaires' disease outbreak sickens dozens in New York City
A fourth person has died in connection with a Legionnaires' disease outbreak in New York City, health officials disclosed Thursday as they revealed that some cooling towers that tested positive for the bacteria are in city-run buildings. The outbreak in Central Harlem has sickened dozens since it began in late July. Seventeen people were hospitalized as of Thursday, according to the health department. The bacteria that causes Legionnaires' disease had been discovered in 12 cooling towers on 10 buildings, including a city-run hospital and sexual health clinic, health officials said. Remediation efforts have been completed on 11 of the cooling towers, with the final tower's remediation required to be completed Friday. Legionnaires' disease is a type of pneumonia that is caused by Legionella bacteria, which grow in warm water and spread through building water systems. The city's outbreak has been linked to cooling towers, which use water and a fan to cool buildings. People usually develop symptoms — a cough, fever, headaches, muscle aches and shortness of breath — between two days to two weeks after exposure to the bacteria, according to the U.S. Centers for Disease Control and Prevention. Dr. Michelle Morse, the city's acting health commissioner, said new cases in the Central Harlem outbreak have begun to decline 'which indicates that the sources of the bacteria have been contained.' She urged people who live or work in the area to contact a health care provider if they develop flu-like symptoms.
Daily Mail
an hour ago
- Daily Mail
New antibiotics capable of killing drug-resistant gonorrhoea are developed... by AI
New antibiotics capable of killing drug-resistant gonorrhoea have been developed by AI. Experts believe that Artificial Intelligence could signify a 'second golden age' of antibiotic discovery, after creating two drugs that could be capable of killing superbugs such as gonorrhea and MRSA. Led by Professor James Collins at the Massachusetts Institute of Technology (MIT), a specialist research team used generative AI algorithms to interrogate 36million compounds. The experts then trained the AI to help it learn how bacteria was affected by different molecular structures built of atoms in order to design new antibiotics. In order to do this, they gave it the chemical structure of known compounds and data on their ability to hinder the growth of different bacteria species. Throughout the study, published in the journal Cell, anything too similar to the current antibiotics available, or with the potential to be toxic to human beings, was eradicated. Scientists also had to ensure that the system was indeed creating medicine, rather than soap. Two approaches were then attempted to help design antibiotics with AI - the first searching through millions of chemical fragments, while the other allowed AI to control the process entirely. The result was innovative AI-generated drugs for both the sexually transmitted infection and possibly life-threatening MRSA (methicillin-resistant Staphylococcus aureus). Both were found to be capable of killing the superbugs in laboratory and animal tests. It marks a significant move in the use of AI among researchers hoping to combat the rise in deaths caused by an overuse of antibiotics. The bacteria-fighting medicines are crucial for clearing infections and preventing life-threatening complications. However, hard-to-treat cases are on the rise as the bacteria that cause them are becoming increasingly impervious to the drugs. At least one million annual deaths due to antibiotic resistance have been recorded globally since 1990, according to the University of Oxford. Over the past decade, the NHS has made a concerted effort to reduce the number of antibiotic prescriptions given to patients, in order to slow the spread of superbugs. Yet 37 million prescriptions were written in the UK in 2023, compared to 36 million in 2022 and 31 million in 2020, official figures show. However, clinical trials and a further refinement of the possible drugs, estimated to take between one and two years, will be required before the drugs can be prescribed. WHAT IS ANTIBIOTIC RESISTANCE? Bacteria can become drug resistant when people take incorrect doses of antibiotics or if they are given out unnecessarily. The World Health Organization (WHO) has previously warned if nothing is done the world is heading for a 'post-antibiotic' era. Bacteria can become drug resistant when people take incorrect doses of antibiotics or if they are given out unnecessarily. Former chief medical officer Dame Sally Davies claimed in 2016 that the threat of antibiotic resistance is as severe as terrorism. Dr Andrew Edwards, from the Fleming Initiative and Imperial College London, told the BBC that the work has 'enormous potential' and indicates a 'novel approach to identifying new antibiotics'. Meanwhile, Professor Chris Dawson, from the University of Warwick, said that the drugs could mark a 'significant step forward as a tool for antibiotic discovery'. However, Professor Collins warned that 'better models' are still required for AI to truly help tackle drug-resistant infections. Other concerns raised by medical experts included how complex the AI-designs are to manufacture, with just two drugs created out of 80 initial designs. Meanwhile, a new antibiotic designed to treat drug-resistant infections would ideally be used as little as possible in order to ensure its success. This, therefore, raises questions about the likelihood of a commercial profit being possible. In 2024, an estimated 71,802 people were diagnosed with gonorrhoea, according to government figures. Meanwhile, 910 cases of MRSA were recorded across England from 2023 to 2024, marking an increase of 15.6 per cent from 2022 to 2023. While MRSA can live harmlessly on the skin, the bacteria has the potential to become deadly if it enters the body.
